Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials

OBJECTIVE: We performed a systematic review and meta-analysis of the cognitive effectiveness and safety of lecanemab on subjects with Alzheimer's disease (AD). METHODS: We screened the literature published before February 2023 in PubMed, Embase, Web of Science, and Cochrane that were searched f...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yue, Chi, Yuewei, Zhang, Qingyuan, Ma, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196238/
https://www.ncbi.nlm.nih.gov/pubmed/37213538
http://dx.doi.org/10.3389/fnagi.2023.1169499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196238/
https://www.ncbi.nlm.nih.gov/pubmed/37213538
http://dx.doi.org/10.3389/fnagi.2023.1169499

Ejemplares similares